Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Improved Synthesis of New FDA-Approved Treatment for KRAS G12C Mutation in Non-small Cell Lung Cancer.

Literature DB >> 34413935

Improved Synthesis of New FDA-Approved Treatment for KRAS G12C Mutation in Non-small Cell Lung Cancer.

Robert B Kargbo¹.

Abstract

Entities: Chemical

Year: 2021 PMID： 34413935 PMCID： PMC8365624 DOI： 10.1021/acsmedchemlett.1c00330

Source DB: PubMed Journal: ACS Med Chem Lett ISSN： 1948-5875 Impact factor: 4.632

Keyword Cloud
References

× No keyword cloud information.

5 in total

Review 1. Targeting mutant KRAS.

Authors: Daniel A Erlanson; Kevin R Webster
Journal: Curr Opin Chem Biol Date: 2021-04-07 Impact factor: 8.822

Review 2. RAS as a positive predictive biomarker: focus on lung and colorectal cancer patients.

Authors: Umberto Malapelle; Francesco Passiglia; Chiara Cremolini; Maria Lucia Reale; Francesco Pepe; Pasquale Pisapia; Antonio Avallone; Diego Cortinovis; Alfonso De Stefano; Matteo Fassan; Gabriella Fontanini; Domenico Galetta; Calogero Lauricella; Angela Listì; Fotios Loupakis; Fabio Pagni; Filippo Pietrantonio; Sara Pilotto; Luisella Righi; Andrea Sartore Bianchi; Hector Soto Parra; Marcello Tiseo; Michela Verzè; Giancarlo Troncone; Silvia Novello
Journal: Eur J Cancer Date: 2021-02-12 Impact factor: 9.162

Improved Synthesis of New FDA-Approved Treatment for KRAS G12C Mutation in Non-small Cell Lung Cancer.

Review 1. Targeting mutant KRAS.

Review 2. RAS as a positive predictive biomarker: focus on lung and colorectal cancer patients.

3. Suppressing Nucleotide Exchange to Inhibit KRAS-Mutant Tumors.

Review 4. KRAS-Mutant Non-Small Cell Lung Cancer: An Emerging Promisingly Treatable Subgroup.

Review 5. KRAS G12C-Mutant Non-Small Cell Lung Cancer: Biology, Developmental Therapeutics, and Molecular Testing.